Mariano Barbacid
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Mariano
Contact Mariano, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
A disease model resource reveals core principles of tissue-specific cancer evolution
Abstract Oncogenes such as KRAS display marked tissue specificity in their oncogenic potential, genetic interactions and phenotypic effects, but the underlying determinants remain largely unresolved1,2,3,4,5. Here, to address these questions, we developed the Mouse Cancer Cell line Atlas, a broad-utility resource of 590 comprehensively characterized models across a wide range of entities (www.mcca.tum.de).
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome - Nature Aging
|
Abstract Platinum-based chemotherapy is commonly used for non-small cell lung cancer (NSCLC) and high-grade serous ovarian cancer (HGSOC) treatments, yet clinical outcomes remain poor. Cellular senescence and its associated secretory phenotype (SASP) can have multiple tumor-promoting activities, but both are largely unexplored in these cancers.
By David Macías, Jianfeng Ge, Ioana Olan, Jose Martin, Jóse Martin, José Martín Verified, Hui-Ling Ou, Muhamad Hartono, Mary Denholm, Rosalind Kieran, Reuben J. Hoffmann, Mark Dane, Dimitris Veroutis, Guillermo Medrano, Francisca Mulero, Mercedes Jimenez-Linan, Ljiljana Fruk, Carla Martins, Mariano Barbacid, Vassilis G. Gorgoulis, James E. Korkola, Doris Rassl, Gary J Doherty, Robert C Rintoul, Masashi Narita, James Brenton, Daniel Muñoz-Espín, Estela González-Gualda, Samir Morsli, María Pilar Puerto-Camacho
|
Nature
Verified
The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies
FDA U.S. Food and Drug Administration GAP GTPase-activating protein GDP guanosine diphosphate GTP guanosine triphosphate MAPK mitogen-activated protein kinase NMPA National Medical Products Administration PI3K phosphatidyl inositol 3-kinase RAS proteins are small GTPases that cycle between an inactive, GDP-bound (OFF) state and an active, GTP-bound (ON) state, in which they transmit signals from extracellular receptors to promote cell proliferation or block apoptosis, among other functions.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mariano
Contact Mariano, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack